Dobmeier Eric

Janux Therapeutics, Inc. · Director

Dobmeier Eric is listed in filings as Director at Janux Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2025, including 10 public disclosures. Recent filings connect the profile to Janux Therapeutics, Inc. (JANX) and Structure Therapeutics Inc (GPCR). The current snapshot covers public activity from Jun 27, 2024 to Jun 25, 2025. Reported amounts are shown as $373.1K to $183.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.